Investors interested in Finance stocks should always be looking to find the best-performing companies in the group. Has Oscar Health, Inc. (OSCR) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out. Oscar Health, Inc. is a member of our Finance group, which includes 863 different companies and currently sits at #12 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Oscar Health, Inc. is currently sporting a Zacks Rank of #1 (Strong Buy). Within the past quarter, the Zacks Consensus Estimate for OSCR's full-year earnings has moved 79.3% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger. Our latest available data shows that OSCR has returned about 83.4% since the start of the calendar year. At the same time, Finance stocks have gained an average of 8.3%. This means that Oscar Health, Inc. is performing better than its sector in terms of year-to-date returns. Another Finance stock, which has outperformed the sector so far this year, is Palomar (PLMR). The stock has returned 48.7% year-to-date. The consensus estimate for Palomar's current year EPS has increased 10% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy). Looking more specifically, Oscar Health, Inc. belongs to the Insurance - Multi line industry, which includes 39 individual stocks and currently sits at #173 in the Zacks Industry Rank. Stocks in this group have gained about 6.3% so far this year, so OSCR is performing better this group in terms of year-to-date returns. Palomar, however, belongs to the Insurance - Property and Casualty industry. Currently, this 40-stock industry is ranked #42. The industry has moved +14.2% so far this year. Oscar Health, Inc. and Palomar could continue their solid performance, so investors interested in Finance stocks should continue to pay close attention to these stocks. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oscar Health, Inc. (OSCR):Free Stock Analysis Report Palomar Holdings, Inc. (PLMR):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Is Oscar Health (OSCR) Outperforming Other Finance Stocks This Year?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...